1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2022Impact of Long-Term Dienogest Therapy on Quality of Life in Asian Women with Endometriosis: the Prospective Non-Interventional Study ENVISIOeN REPRODUCTIVE SCIENCES
2022IMMUNE PROPERTIES OF TUMOR-INFILTRATING LYMPHOCYTES IN OVARIAN CLEAR CELL CARCINOMA RELATIVE TO OVARIAN HIGH-GRADE SEROUS CARCINOMAINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 (HER2) RECEPTOR EXPRESSION AND ITS DYNAMIC CHANGE IN OVARIAN CANCER PATIENTSINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022High FKBPL expression contributes to cell proliferation by regulating the cell cycle and affects prognosis in ovarian cancer patientsINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022HIGH EXPRESSION OF VACUOLAR-ATPASE SUBUNIT ATP6V1B1 PROMOTES POOR PROGNOSIS AND TUMORIGENIC CHARACTERISTICS IN EPITHELIAL OVARIAN CANCERINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022HIGH EXPRESSION OF TRAFFICKING PROTEIN TRANSMEMBRANE P24 TRAFFICKING PROTEIN9 PROMOTES POOR PROGNOSIS OF EPITHELIAL OVARIAN CANCERINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022HIGH EXPRESSION OF PHOSPHODIESTERASE 1 (PDE1A) PROMOTES POOR PROGNOSIS AND ASSOCIATED WITH PLATINUM BASED CHEMOTHERAPY RESISTANCE IN EPITHELIAL OVARIAN CANCERINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Genomic DNA analysis of cervical smear samples of endometrial cancer with next-generation sequencing: A prospective studyANNALS OF ONCOLOGY
2022Feasibility of longitudinal monitoring of whole blood-based circulating tumour DNA (ctDNA) in patients with endometrial cancerANNALS OF ONCOLOGY
2022Expression profiles of id and E2A in ovarian cancer and sup-pression of ovarian cancer by the E2A isoform E47INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Efficacy and safety of GX-188E, a therapeutic DNA vaccine, combined with pembrolizumab in HPV 16- and/or 18- positive advanced cervical cancer (phase II): Safe and effective in both PD-L1 positive and negativeANNALS OF ONCOLOGY
2022Dynamic changes of peripheral regulatory t cells during parp inhibitor maintenance therapy in patients with ovarian cancerINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trialINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Comprehensive profiling of cervix cancer patients using tumor next-generation sequencing (NGS) and immunohistochemistry (IHC)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Clinical relevance of red blood cell distribution as prognostic marker in endometrial carcinomaINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Clinical outcomes of BRCA1/2 pathogenic variants in ovarian cancer cluster region in patients with primary peritoneal, epithelial ovarian, and fallopian tube cancerGYNECOLOGIC ONCOLOGY
2022An open label, single arm, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16 or 18 positive recurrent cervical cancer INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022Added value of sentinel lymph node biopsy in patients with negative lymph node on triple pre-operative imagesINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2022A double-blind, 4-block randomized, placebo-controlled, adaptive phase 2/3 trial to confirm efficacy of BLS-ILB-E710c in patients with cervical intraepithelial neoplasia 2/3 with extension study INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2023Chromosomal Abnormality, fetal/neonatal Death and Socioeconomic Status: A Prospective Cohort StudyMATERNAL AND CHILD HEALTH JOURNAL

Recent Submissions

Browse

Links